Wenhai Huang Selected Research

potassium phosphate (potassium dihydrogen phosphate)

2/2010	Conversion of borate-based glass scaffold to hydroxyapatite in a dilute phosphate solution.
5/2009	Mechanism for converting Al2O3-containing borate glass to hydroxyapatite in aqueous phosphate solution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenhai Huang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 12/2004
8	Infections 08/2014 - 10/2009
6	Osteomyelitis 03/2014 - 10/2009
5	Weight Loss (Weight Reduction) 10/2010 - 02/2009
3	Alzheimer Disease (Alzheimer's Disease) 09/2019 - 08/2010
3	Wounds and Injuries (Trauma) 07/2018 - 01/2015
1	Lymphoma (Lymphomas) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 05/2018
1	Inflammation (Inflammations) 01/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Carcinogenesis 01/2017
1	Bacterial Infections (Bacterial Infection) 08/2014
1	Insulin Resistance 11/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2011
1	Bone Resorption 02/2011
1	Dehydration (Water Stress) 01/2009
1	Rupture 01/2009

Drug/Important Bio-Agent (IBA)

9	BoratesIBA 07/2018 - 10/2009
4	Vancomycin FDA LinkGeneric 03/2014 - 10/2009
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2014 - 08/2010
4	SolutionsIBA 10/2010 - 02/2009
3	Biocompatible Materials (Biomaterials)IBA 08/2014 - 12/2004
3	ChitosanIBA 10/2013 - 08/2010
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2018
2	snake venom protein C activatorIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	MetalsIBA 09/2019 - 08/2010
2	CollagenIBA 12/2018 - 07/2018
2	CopperIBA 07/2018 - 01/2015
2	Calcium Sulfate (Alabaster)IBA 03/2014 - 10/2009
2	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013 - 07/2013
2	potassium phosphate (potassium dihydrogen phosphate)IBA 02/2010 - 05/2009
2	Durapatite (Hydroxylapatite)IBA 02/2010 - 02/2010
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2021
1	Poly (ADP-Ribose) Polymerase-1IBA 12/2020
1	DNA Repair EnzymesIBA 12/2020
1	ibrutinibIBA 12/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Keratin-19 (Keratin 19)IBA 01/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2020
1	N-dodecyl-L-lysine amideIBA 10/2019
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	Cholinergic Agents (Cholinergics)IBA 09/2019
1	CobaltIBA 01/2019
1	IonsIBA 01/2019
1	pirfenidoneIBA 12/2018
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 12/2018
1	Vitamin E FDA LinkGeneric 07/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 07/2018
1	ErbB Receptors (EGF Receptor)IBA 05/2018
1	buteinIBA 05/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2018
1	LipopolysaccharidesIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Biological ProductsIBA 01/2017
1	LuciferasesIBA 01/2017
1	AlkaloidsIBA 10/2016
1	Silicone Elastomers (SE 30)IBA 03/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Histones (Histone)IBA 01/2016
1	Polymethyl Methacrylate (Sol)IBA 08/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2012
1	QuinoxalinesIBA 12/2011
1	LigandsIBA 12/2011
1	Therapeutic UsesIBA 11/2011
1	Insulin (Novolin)FDA Link 11/2011
1	StrontiumIBA 02/2011
1	PowdersIBA 08/2010
1	TeicoplaninIBA 08/2010
1	Chelating AgentsIBA 08/2010
1	BoronIBA 02/2010
1	Pharmaceutical PreparationsIBA 02/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 02/2010
1	P-2 (P 2)IBA 02/2010
1	SuspensionsIBA 01/2009
1	Bentonite (Montmorillonite)IBA 01/2009
1	Siloxanes (Siloxane)IBA 01/2009

Therapy/Procedure

2	Oral Administration 01/2022 - 12/2018
1	Castration 01/2021
1	Injections 03/2014
1	Drug Therapy (Chemotherapy) 12/2012
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2011
1	Therapeutics 10/2011
1	Debridement 07/2011
1	Microspheres (Microsphere) 01/2009